Details of the Drug Reposition

General Information of This Drug (ID: DMOCHVE)

Drug Name
SL-401   DMOCHVE

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Myeloproliferative neoplasm DIS5KAPA 2A20 Phase 1/2 [1]
Blastic plasmacytoid dendritic cell neoplasm DISLEJU7 2A60.5 Phase 1/2 [2]
Multiple myeloma DISEWP9B 2A83 Phase 1/2 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02113982) SL-401 in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia. U.S. National Institutes of Health.